RISK FACTORS FOR TYPE 2 DIABETES
Age 40 years or older
First degree relative with type 2 diabetes
African, Arab, Asian, Hispanic, Indigenous, South Asian
Overweight
Drugs associated with diabetes
Glucocorticoids
Atypical antipsychotics
Statins
Highly active antiretroviral therapy
Anti-rejection drugs
LIFESTYLE INTERVENTIONS
Nutrition decreases A1C by 1-2%
Metformin decreases A1C by 1-1.5%
Sulfonylureas, repaglinide, GLP1 RA
TZDs decrease A1C by 1%
SGLT2i decrease A1C by 0.5-0.8%
Exercise decreases A1C by 0.5-0.7%
DPP4I decreases A1C by 0.5-0.7%
Diabetes is diagnosed using blood tests that measure sugar levels. The main ones are:
Fasting Plasma Glucose (FPG) ≥ 7.0 mmol/L → Check sugar after fasting for 8+ hours
A1c ≥ 6.5% → Measures the average sugar over 3 months
2-hour Plasma Glucose in OGTT ≥ 11.1 mmol/L → After drinking a sugary drink, if blood sugar is too high
Random Plasma Glucose ≥ 11.1 mmol/L + symptoms → If high sugar is found randomly in a person with symptoms like excessive thirst, urination, and fatigue
Screening is important because diabetes can be silent for years. We screen:
Everyone over 40 every 3 years
Earlier if high risk (obesity, family history, high blood pressure, history of gestational diabetes, etc.)
Think of diabetes like a leaky faucet. Medications can help, but if you don’t tighten the faucet (lifestyle changes), the water (blood sugar) will keep rising.
Diet: Eating fewer processed carbs/sugars and more fiber, protein, and healthy fats helps slow down sugar spikes.
Exercise: Increases insulin sensitivity, so the body can use sugar more efficiently.
Weight Loss (if applicable): Losing even 5-10% of body weight can improve blood sugar control.
Lifestyle changes can sometimes delay or even reverse diabetes (in early stages).
Medications are chosen based on the patient’s specific needs:
Medication Class | Benefits | Risks | Who it's best for |
---|---|---|---|
Metformin | Weight neutral, cheap, good for the heart | GI upset, B12 deficiency | First-line for almost everyone |
SGLT2 inhibitors (-flozins) | Weight loss, good for kidneys & heart | Increased urination, risk of infections | Good for heart failure & kidney disease |
GLP-1 RAs (-tides) | Weight loss, heart benefits | Injectable, GI side effects | Good for weight loss & heart benefits |
Sulfonylureas (gliclazide, glimepiride) | Cheap, effective | Can cause low sugar (hypoglycemia), weight gain | Use if cost is an issue |
Insulin | Lowers sugar effectively | Weight gain, hypoglycemia | Used later when other meds aren't enough |
💡 Deprescribing: If a patient achieves remission or has side effects, we can stop some meds (e.g., sulfonylureas first).
Similarities: All lower blood sugar but in different ways.
Differences: Some help with weight loss (SGLT2i, GLP-1 RAs), some cause hypoglycemia (insulin, sulfonylureas), and some protect the heart/kidneys (SGLT2i, GLP-1 RAs).
Type 2 diabetes gets worse over time because beta cells wear out and make less insulin.
Remission (A1c < 6.5% without meds) is possible early on with weight loss and aggressive lifestyle changes (especially with significant weight loss from bariatric surgery).
A1c goals are personalized:
Patient Type | A1c Target | Why? |
---|---|---|
Young & healthy | ≤6.5% | Lowering A1c reduces long-term complications |
Older adults, risk of hypoglycemia | 7.1 - 8.5% | Prevents falls, hypoglycemia |
CKD or heart disease | ≤7.0% | Balance sugar control & avoiding harm |
Too much sugar lowering can be dangerous if it causes hypoglycemia, especially in older adults. Some trials showed aggressive control did not reduce death rates (e.g., ACCORD trial).
Some meds do more than just lower sugar. Big trials (like EMPA-REG, LEADER) show that:
SGLT2 inhibitors & GLP-1 RAs protect the heart and kidneys.
Sulfonylureas & insulin lower sugar but don’t have heart/kidney benefits.
Depends on medications:
Medication | Monitoring Frequency |
---|---|
Diet/lifestyle only | No regular checks needed |
Oral meds (except insulin/SUs) | Occasionally |
Sulfonylureas | Daily, risk of low sugar |
Insulin (basal only) | Once daily or few times a week |
Insulin (multiple doses) | Multiple times per day |
Definition: Blood sugar < 4.0 mmol/L
u can literally die after being in a coma —> hypoglycemia is not epic
Symptoms:
Shaky, sweaty, dizzy, hungry, fast heartbeat, confusion
Nocturnal = nightmare, restless sleep, sweating, morning headache
** Beta blockers might mask symptoms of hypoglycemia EXCEPT SWEATING
—> Beta blockers are beta males who are stinky sweaters!!!!!!!
Adrenergic symptoms = A FOR ANXIETY
These occur first, followed by neuroglycopenic symptoms
MAY NOT OCCUR in ppl with impaired awareness of hypoglycemia
Trembling, palpitation, swearing, anxiety, hunger, nausea, tingling
Neuroglycopenic = THINK OF A DRUNK PERSON
Difficulty concentrating, confusion, weakness, drowziness, slurred speech, headache, dizziness
Treatment: "Rule of 15" → 15g sugar (e.g., juice, glucose tabs), wait 15 min, recheck
If after 3 attempts you’re still hypoglycemic, GO TO HOSPITAL !!! YOU FAILED YOURSELF DUMMY.
Prevention: Eat regular meals, adjust meds if needed
1) LEVEL 1 HYPOGLYCEMIA
Glucose level below normal (3-3.9)
Autonomic symptoms present , no neuroglycopenic symptoms
2) LEVEL 2 HYPOGLYCEMIA
Glucose level below normal (<3)
Neuroglycopenic symptoms without significant impact on mental status (they ain’t going psycho)
Autonomic symptoms may or may not be present
3) LEVEL 3 HYPOGLYCEMIA
Glucose levels VERYYY BELOW normal
Neuroglycopenic symptoms that are BAD (altered physical / mental status)
Requires assistance to treat
COUNSELLING TIPS:
Important esp for bozos on sulfonylureas, meglitinides, insulin
Review possible causes w them (delayed meal, increased activity, drugs, alcohol)
REDUCING HYPOGLYCEMIA RISK DURING EXERCISE
Reduce bolus dose of insulin at time of exercise
Reduce or suspend basal insulin for exercise duration (if activity < 45 minutes)
Lower basal rate overnight after exercise by ~20%
Increase carbohydrate consumption prior to, during, and after exercise as necessary
**BASIC TIPS —> Just reduce both types of insulin and eat like a fatty mc fatty bc I guess you ain’t gonna be at a net calorie deficit when u exercise LOSERRRR
HYPOGLYCEMIA AND DRIVING
You gotta be 5 to drive —> (Levels <5 = DO NOT DRIVE)
We start insulin when other meds aren’t enough (A1C is above target AND patient is on 2-4 maximal doses of non insulin medications)
Starting dose: Basal insulin (e.g., glargine) at 10 units/day or 0.1-0.2 units/kg (5-10 units at bedtime)
Most people will eventually require 25-50 units of basal insulin
Adjusting: Increase by 1 unit each morning if blood glucose above 7, check A1C in 3 months
For complex cases (mealtime insulin), we follow a basal-bolus regimen based on carbohydrate intake and blood sugar levels.
DISCONTINUING MEDICATIONS WHEN STARTING INSULIN ?
Don’t discontinue other diabetes medications UNLESS its
Rosiglitzone or Pioglitazone
in which case…. u should prob discontinue lol
BOLUS INSULIN (Nutritional Insulin)
Start with 2 units w/ largest meal (or meal that has highest postprandial reading)
Adjust weekly —> Eventually most ppl have 50% basal 50% bolus
DISCONTINUE OR REDUCE DOSE of sulfonylureas, repaglinide (to decrease risk of hypoglycemia)
Feature | Type 1 | Type 2 |
---|---|---|
Cause | Autoimmune (body attacks beta cells) | Insulin resistance & beta cell dysfunction |
Onset | Sudden, usually young | Gradual, usually older |
Insulin needed? | Always | Sometimes |
Main treatment | Insulin | Lifestyle + oral meds ± insulin |
🔹 Depends on type of diabetes & medications:
GENERALLY:
Check once daily for once a day injections
Twice daily for twice a day injections etc
✅ Exception: If sick, fasting, or changing meds → check more frequently!
After metformin, the choice depends on patient factors:
If heart disease or kidney disease? 🚨 → SGLT2 inhibitor (-flozin) or GLP-1 RA (-tide)
If weight loss is needed? 🏋 → GLP-1 RA or SGLT2i
If cost is an issue? 💰 → Sulfonylurea or TZD
If avoiding hypoglycemia? ⚠ → DPP-4i, GLP-1 RA, SGLT2i
🔹 3rd line = add another agent from a different class if A1c is still high.
Heart/kidney disease? → SGLT2i/GLP-1 RA for protection
Hypoglycemia risk? → Avoid sulfonylureas & insulin
Weight loss goal? → Use SGLT2i/GLP-1 RA
Cost issues? → Sulfonylureas/TZDs are cheaper
Elderly/fall risk? → Avoid sulfonylureas & high insulin doses
🛑 Start insulin when:
A1c ≥ 10% OR fasting glucose > 16.7 mmol/L
Symptoms of hyperglycemia (weight loss, excessive thirst/urination, fatigue)
Oral meds aren’t enough anymore
🔹 Starting dose (basal insulin):
10 units/day OR 0.1–0.2 units/kg/day
Adjust by 1–2 units every 3 days until fasting sugar reaches goal
🔹 If post-meal sugars are still high:
Add bolus insulin before meals (start with 4 units & adjust)
💡 Depends on patient needs!
Insulin Type | Examples | Best For |
---|---|---|
Basal (long-acting) | Glargine (Lantus), Detemir (Levemir), Degludec (Tresiba) | Type 2 needing simple control |
Bolus (rapid-acting) | Lispro (Humalog), Aspart (NovoRapid), Glulisine (Apidra) | Mealtime control |
Premixed insulin | Humulin 30/70, Novomix 30 | Patients who need fewer injections |
🚨 Basal-first strategy is preferred in Type 2 diabetes.
⚠ Some meds can cause insulin resistance or increase blood sugar:
Glucocorticoids (e.g., prednisone) → Most common!
Antipsychotics (e.g., olanzapine, clozapine)
Beta-blockers (mask hypoglycemia, may increase sugar)
Thiazide diuretics (at high doses)
Statins (slight risk but benefits outweigh it!)
1⃣ Start with lifestyle changes (diet, exercise, weight loss)
2⃣ Metformin (unless contraindicated)
3⃣ Add second-line agent based on patient factors (SGLT2i, GLP-1 RA, sulfonylurea, etc.)
4⃣ If still high A1c, add a 3rd agent
5⃣ If still uncontrolled, start basal insulin
6⃣ If needed, add mealtime insulin
Definition: Blood sugar <4.0 mmol/L
Symptoms:
Mild: Shaky, hungry, fast heartbeat
Moderate: Confused, weak, blurred vision
Severe: Seizures, unconsciousness
Management: "Rule of 15"
Eat 15g of fast sugar (glucose tabs, juice, candy)
Wait 15 min, recheck sugar
Repeat if needed
Prevention: Eat regularly, adjust meds, avoid excess alcohol
🚨 Alcohol can cause hypoglycemia, especially with insulin/sulfonylureas!
Drink with food to prevent sugar crashes
Limit to ≤2 drinks/day
Monitor sugar carefully
✅ They’re still an option but…
Weaker than SGLT2i & GLP-1 RA
No heart/kidney benefits
Main use: If a patient can’t tolerate SGLT2i or GLP-1 RA
✅ Yes, but selectively:
Good for cost-conscious patients
Works well but risk of hypoglycemia & weight gain
Use gliclazide (better safety than glyburide/glimepiride)
Blood sugar monitoring varies by diabetes type & meds
2nd/3rd line agents depend on patient factors
Insulin is started when A1c ≥10% or symptoms appear
Basal insulin first, adjust slowly
Certain meds increase diabetes risk
DPP-4i & sulfonylureas still have a role but aren’t first choice
Hypoglycemia must be treated & prevented
Alcohol can worsen diabetes control
If diabetes isn’t properly managed, high blood sugar over time damages blood vessels, leading to two main types of complications:
Eye damage (retinopathy, cataracts) 👁 → Can lead to blindness
Kidney disease (nephropathy) 🩸 → Can lead to dialysis
Nerve damage (neuropathy) ⚡ → Can cause numbness, pain, and increase risk of amputations
Foot problems 🦶 → Poor healing + nerve damage = infections & ulcers
Heart disease & high blood pressure ❤ → Increased risk of heart attacks
Stroke 🧠 → Poor blood flow to the brain = major disability risk
✅ Proper management (meds + lifestyle) can delay or prevent these complications and help people live longer & healthier lives!
🔹 It depends—lowering blood sugar is important, but too aggressive control can sometimes be harmful!
🔬 Key Trials to Know:
1⃣ ACCORD Trial 🏥
Found that pushing A1c too low (<6.0%) too quickly actually increased the risk of death in some people (esp. those with heart disease).
Lesson? Don’t chase perfect numbers—balance is key!
2⃣ Rosiglitazone Meta-Analysis 💊
This diabetes drug (rosiglitazone) lowered A1c but increased the risk of heart attacks!
Lesson? Lowering sugar alone is NOT enough—we need meds that also protect the heart!
3⃣ SAVOR-TIMI 53 (Saxagliptin Trial) 📊
Showed that saxagliptin (DPP-4 inhibitor) lowered blood sugar, but increased the risk of heart failure.
Lesson? We must consider long-term outcomes, not just glucose control.
🔹 Bottom Line: Managing diabetes isn’t just about sugar levels—it’s about preventing long-term harm!
❌ No screening needed!
Why? No proven way to prevent or delay Type 1 diabetes even if we catch it early.
✅ Screen everyone ≥40 years old OR those at high risk!
How? Use a Fasting Plasma Glucose (FPG) and/or A1c test every 3 years.
If high risk? (33% chance of diabetes in 10 years) → Screen earlier & more often!
If someone doesn’t have symptoms, diabetes is diagnosed if any two of these are met:
Test | Diabetes Diagnosis |
---|---|
A1c (average blood sugar over 3 months) | ≥6.5% (on 2 separate tests) |
Fasting Blood Glucose (FPG) | ≥7.0 mmol/L (on 2 separate tests) |
A1c ≥6.5% + FPG ≥7.0 mmol/L | ✅ Diagnosed immediately |
🚨 If symptoms are present (thirst, urination, weight loss, etc.), ONE abnormal test is enough!
⚠ Not everyone has symptoms! But when they do, they might experience:
Excessive thirst (polydipsia) 🥤
Frequent urination (polyuria) 🚽
Unexplained weight loss or gain ⚖
Extreme fatigue 🛏
Blurred vision 👀
Frequent infections 🦠 (UTIs, yeast infections, etc.)
Slow healing cuts & bruises 🩹
Tingling/numbness in hands & feet 🦶
Erectile dysfunction in men 🍆
💡 Remember: Some people don’t have symptoms at all, which is why screening is important!
✅ Untreated high sugars = microvascular & macrovascular complications (eye, kidney, nerve, heart, stroke)
✅ Lowering sugar too aggressively can be dangerous! (ACCORD, Rosiglitazone, SAVOR-TIMI)
✅ Screen for Type 2 diabetes every 3 years in people ≥40 or high risk
✅ Diagnose diabetes with 2 abnormal A1c or fasting glucose tests OR 1 test if symptoms present
✅ Symptoms: Excess thirst, urination, fatigue, infections, slow healing, numbness, vision issues
Feature | Type 1 Diabetes | Type 2 Diabetes | Monogenic Diabetes (MODY) |
---|---|---|---|
Age of Onset | Usually <25 years (but can occur at any age) | Usually >24 years, but increasing in children due to obesity | Usually <25 years (Neonatal diabetes <6 months) |
Weight | Usually thin, but obesity is possible | 90%+ overweight/obese | Similar to general population |
Islet Autoantibodies | Present | Absent | Absent |
C-peptide (measures insulin production) | Low/undetectable | Normal/high | Normal |
Insulin Production | Absent | Present | Usually present |
First-Line Treatment | Insulin | Non-insulin meds → May eventually need insulin | Depends on genetic subtype |
Family History | Rare (5-10%) | Common (75-90%) | Strong family history (multigenerational) |
DKA (Diabetic Ketoacidosis) | Common | Rare | Rare |
📌 Key Takeaway:
Type 1 diabetes → Insulin-dependent from the start
Type 2 diabetes → Lifestyle & meds first, insulin later if needed
MODY → Genetic, may need different treatments
🔹 A person is diagnosed with diabetes if they meet ONE of these criteria:
Test | Diabetes Diagnosis |
---|---|
Fasting Plasma Glucose (FPG) | ≥7.0 mmol/L (no food for 8+ hours) |
A1C (3-month average glucose test) | ≥6.5% (on 2 separate tests, in adults) |
2-hour Plasma Glucose (OGTT) | ≥11.1 mmol/L (after drinking 75g glucose solution) |
Random Plasma Glucose (RPG) | ≥11.1 mmol/L (at any time of day, no fasting required) |
🔹 If NO symptoms:
Repeat the test on a different day to confirm.
If using different tests (e.g., one A1C and one FPG), and both are above the cutoff → diagnosis confirmed.
🔹 If symptoms ARE present (thirst, urination, weight loss, etc.):
Diagnosis is confirmed immediately—no second test needed!
🚨 For suspected Type 1 diabetes (especially in young, thin, or very symptomatic patients), treatment should start immediately—DO NOT delay for confirmatory tests!
🔹 What is A1C?
Measures the % of hemoglobin (HbA1c) bound to glucose in red blood cells.
Reflects average blood sugar over the past 3 months.
📌 A1C is a ‘surrogate marker’ for complications: Lower A1C → Lower risk of diabetes complications!
✅ Advantages:
✔ No fasting required (convenient)
✔ Only needs testing every 3-6 months
✔ Easier for long-term tracking
⚠ Disadvantages:
❌ Does NOT show daily fluctuations (someone could have extreme highs & lows, but A1C looks fine)
❌ Not accurate in certain conditions:
Hemoglobinopathies (e.g., sickle cell disease)
Severe kidney disease
Pregnancy (not used to diagnose gestational diabetes)
❌ Ethnicity & age can affect results
🔹 Fasting Blood Glucose vs. A1C – Which is Better?
Fasting glucose → Shows blood sugar at that exact moment.
A1C → Shows long-term control, but doesn’t reflect daily ups & downs.
📌 Best approach? Use both fasting glucose & A1C to get the full picture!
🔹 A1C in a person WITHOUT diabetes? 4.5-5.9%
🔹 Targets for people WITH diabetes:
A1C Target | Who is it for? |
---|---|
≤6.5% | T2DM patients at low risk of hypoglycemia (to reduce CKD & retinopathy risk) |
≤7.0% | Most adults with Type 1 or Type 2 diabetes |
7.1-8.0% | Functionally dependent patients (older adults, frail, mild dementia, etc.) |
7.1-8.5% | High-risk patients (severe hypoglycemia, limited life expectancy, advanced dementia, etc.) |
🚨 A1C should NOT be the only factor—consider overall health & risk of low blood sugar!
✅ Types of diabetes:
Type 1 → Autoimmune, insulin-dependent
Type 2 → Insulin resistance + secretion problem, treated with meds/lifestyle first
Gestational → Pregnancy-related, risk of future T2DM
MODY → Genetic, may need different treatment
✅ How we diagnose diabetes:
FPG ≥7.0, A1C ≥6.5%, 2hPG (OGTT) ≥11.1, or RPG ≥11.1
If symptomatic → Only one test needed!
If no symptoms → Confirm with a second test!
✅ A1C = Long-term diabetes control marker
Pros: No fasting, every 3-6 months
Cons: Doesn’t show daily swings, affected by some conditions
✅ A1C Targets:
≤6.5% (low-risk T2DM, prevents CKD/eye disease)
≤7.0% (most adults)
7.1-8.5% (elderly, frail, severe hypoglycemia risk)
A higher A1C target is considered to avoid hypoglycemia and over-treatment, particularly in these groups:
Functionally dependent: 7.1-8.0%
History of recurrent severe hypoglycemia (especially with unawareness): 7.1-8.5%
Limited life expectancy: 7.1-8.5%
Frail elderly and/or dementia: 7.1-8.5%
End of life: A1C measurement not recommended; focus on avoiding symptomatic hyperglycemia and hypoglycemia
When adjusting treatment, consider:
Is achieving A1C target still aligned with the patient's health goals?
How far is their actual A1C from their individualized target?
Are there medication side effects or increased risk of hypoglycemia?
Is the patient on a sulfonylurea or insulin (which increases hypoglycemia risk)?
Are any medications too burdensome or expensive for the patient?
A1C (%) | Preprandial PG (mmol/L) | 2-hour Postprandial PG (mmol/L) |
---|---|---|
≤7.0 | 4.0-7.0 | 5.0-10.0 |
If A1C ≤7.0% not achieved despite above targets | 4.0-5.5 | 5.0-8.0 |
Key Takeaways:
Routine SMBG is not required for most adults with type 2 diabetes on oral medications.
SMBG is only useful if the results lead to a specific action (e.g., adjusting meds, diet, or insulin).
If diabetes is managed through diet alone, routine SMBG is not required.
For those using basal insulin, SMBG should be tailored, typically ≤14 tests/week for most patients.
Situations where SMBG may be needed:
Multiple daily insulin injections
Newly diagnosed or starting new medications/insulin
History of or increased risk of hypoglycemia
Acute illness
Significant changes in routine or medications
Unstable or poorly controlled blood glucose
Pregnant or planning pregnancy
Jobs where hypoglycemia is a safety risk
Frail Elderly & Long-Term Care (LTC)
Blood glucose targets are different in frail elderly and LTC patients.
Most people with type 2 diabetes not on insulin can self-test less often without harm.
Testing may be more beneficial in specific cases (e.g., risk of hypoglycemia, routine/med changes, pregnancy).
Don't test if you're not going to act on the results.
Individualize SMBG—some patients may benefit, but routine testing isn’t necessary for everyone.
In frail elderly/LTC, A1C and blood glucose targets are more relaxed, and preventing hypoglycemia is the main priority.